Renita Horton

Dr. Renita Horton

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Biomedical Materials
Verified
Journal Article
Closed access
MAManouk Abkarian
Manouk Abkarian
MFMagalie Faivre
Magalie Faivre
RHRenita Horton
Renita Horton
KSKristian Smistrup
Kristian Smistrup
CBCatherine A Best-Popescu
Catherine A Best-Popescu
HSHoward A Stone
Howard A Stone
Microfluidic tools are providing many new insights into the chemical, physical and physicochemical responses of cells. Both suspension-level and single-cell measurements have been studied. We review our studies of these kinds of problems for red blood cells with particular focus on the shapes of individual cells in confined geometries, the development and use of a 'differential manometer' for evaluating the mechanical response of individual cells or other objects flowing in confined geometries, and the cross-streamline drift of cells that pass through a constriction. In particular, we show how fluid mechanical effects on suspended cells can be studied systematically in small devices, and how these features can be exploited to develop methods for characterizing physicochemical responses and possibly for the diagnosis of cellular-scale changes to environmental factors.

1 January 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FPFrancesco Pasqualini
Francesco Pasqualini
ANAlexander P. Nesmith
Alexander P. Nesmith
RHRenita Horton
Renita Horton
SSSean P. Sheehy
Sean P. Sheehy
KPKevin Kit Parker
Kevin Kit Parker
Efficient contractions of the left ventricle are ensured by the continuous transfer of adenosine triphosphate (ATP) from energy production sites, the mitochondria, to energy utilization sites, such as ionic pumps and the force-generating sarcomeres. To minimize the impact of intracellular ATP trafficking, sarcomeres and mitochondria are closely packed together and in proximity with other ultrastructures involved in excitation-contraction coupling, such as t-tubules and sarcoplasmic reticulum junctions. This complex microdomain has been referred to as the intracellular energetic unit. Here, we review the literature in support of the notion that cardiac homeostasis and disease are emergent properties of the hierarchical organization of these units. Specifically, we will focus on pathological alterations of this microdomain that result in cardiac diseases through energy imbalance and posttranslational modifications of the cytoskeletal proteins involved in mechanosensing and transduction.

25 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RHRenita Horton
Renita Horton
MYMoran Yadid
Moran Yadid
MMMegan L. McCain
Megan L. McCain
SSSean P. Sheehy
Sean P. Sheehy
FPFrancesco Pasqualini
Francesco Pasqualini
KPKevin Kit Parker
Kevin Kit Parker
In vitro disease models offer the ability to study specific systemic features in isolation to better understand underlying mechanisms that lead to dysfunction. Here, we present a cardiac dysfunction model using angiotensin II (ANG II) to elicit pathological responses in a heart-on-a-chip platform that recapitulates native laminar cardiac tissue structure. Our platform, composed of arrays of muscular thin films (MTF), allows for functional comparisons of healthy and diseased tissues by tracking film deflections resulting from contracting tissues. To test our model, we measured gene expression profiles, morphological remodeling, calcium transients, and contractile stress generation in response to ANG II exposure and compared against previous experimental and clinical results. We found that ANG II induced pathological gene expression profiles including over-expression of natriuretic peptide B, Rho GTPase 1, and T-type calcium channels. ANG II exposure also increased proarrhythmic early after depolarization events and significantly reduced peak systolic stresses. Although ANG II has been shown to induce structural remodeling, we control tissue architecture via microcontact printing, and show pathological genetic profiles and functional impairment precede significant morphological changes. We assert that our in vitro model is a useful tool for evaluating tissue health and can serve as a platform for studying disease mechanisms and identifying novel therapeutics.

1 September 2012 in Biomaterials
Verified
Journal Article
Closed access
RHRenita Horton
Renita Horton
DADebra T. Auguste
Debra T. Auguste

17 September 2009 in Regenerative Medicine
Verified
Journal Article
Closed access
RHRenita Horton
Renita Horton
JMJeffrey R Millman
Jeffrey R Millman
CCClark K Colton
Clark K Colton
DADebra T Auguste
Debra T Auguste
Embryonic stem cells and induced pluripotent stem cells have the potential to be a renewable source of cardiomyocytes for use in myocardial cell replacement strategies. Although progress has been made towards differentiating stem cells to specific cell lineages, the efficiency is often poor and the number of cells generated is not suitable for therapeutic usage. Recent studies demonstrated that controlling the stem cell microenvironment can influence differentiation. Components of the extracellular matrix are important physiological regulators and can provide mechanical cues, direct differentiation and improve cell engraftment into damaged tissue. Bioreactors are used to control the microenvironment and produce large numbers of desired cells. This article describes recent methods to achieve cardiomyocyte differentiation by engineering the stem cell microenvironment. Successful translation of stem cell research to therapeutic applications will need to address large-scale cardiomyocyte differentiation and purification, assessment of cardiac function and synchronization, and safety concerns.

1 May 2021 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
PDF file
SIShelby C. Inbody
Shelby C. Inbody
BSBridgett E. Sinquefield
Bridgett E. Sinquefield
JLJoshua P. Lewis
Joshua P. Lewis
RHRenita Horton
Renita Horton
Traditional tissue culture platforms have been around for several decades and have enabled key findings in the cardiovascular field. However, these platforms failed to recreate the mechanical and dynamic features found within the body. Organs-on-chips (OOCs) are cellularized microfluidic-based devices that can mimic the basic structure, function, and responses of organs. These systems have been successfully utilized in disease, development, and drug studies. OOCs are designed to recapitulate the mechanical, electrical, chemical, and structural features of the in vivo microenvironment. Here, we review cardiovascular-themed OOC studies, design considerations, and techniques used to generate these cellularized devices. Furthermore, we will highlight the advantages of OOC models over traditional cell culture vessels, discuss implementation challenges, and provide perspectives on the state of the field.